Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma and urinary salbutamol after inhaled vs oral administration in asthmatics and elite athletes
2008-000670-20Phase 4Completed
- Sponsor
- Respitatory and Allergy Research Unit
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of salbutamol in asthma and exercise-induced bronchospasm (EIB) (3 arms), sponsored by Respitatory and Allergy Research Unit. Primary endpoints: Plasma salbutamol concentration and Urine salbutamol concentration. Started Mar 2008; status: completed.
02
Drugs
salbutamol
03
Conditions
asthmaexercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on 2008-000670-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000670-20.